IP Library Granted Patent US 9,056,043
Granted Patent B2
US 9,056,043 · App. 13/978,557 · Granted Jun 16, 2015

Dental compositions comprising ethylenically unsaturated addition-fragmentation agent

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,056,043
App. No.
13/978,557
Granted
Jun 16, 2015
Kind
B2
Abstract

Dental compositions are described comprising an addition-fragmentation agent comprising at least one ethylenically unsaturated terminal group and a backbone unit comprising an α,β-unsaturated carbonyl; at least one monomer comprising at least two ethylenically unsaturated group; and inorganic oxide filler. The addition-fragmentation agent is preferably free-radically cleavable. The addition-fragmentation agent preferably comprises at least two ethylenically unsaturated terminal groups, such as (meth)acTylate groups. In some embodiments, the addition-fragmentation agent has the formula: wherein R 1 , R 2 and R 3 are each independently Z m , -Q-, a (hetero)alkyl group or a (hetero)aryl group with the proviso that at least one of R 1 , R 2 and R 3 is Z m -Q-; Q is a linking group have a valence of m+1; Z is an ethylenically unsaturated polymerizable group; m is 1 to 6; each X1 is independently —O— or —NR 4 —, where R 4 is H or C 1 -C 4 alkyl; and n is 0 or 1. Also described are dental articles prepared from a dental composition comprising an addition-fragmentation agent and methods of treating a tooth surface.

Claims (42)

1. A dental composition comprising:

an addition-fragmentation agent of the formula:

wherein

R 1 , R 2 and R 3 are each independently Z m -Q-, a (hetero)alkyl group or a (hetero)aryl group with the proviso that at least one of R 1 , R 2 and R 3 is Z m -Q-;

Q is a linking group have a valence of m+1;

Z is an ethylenically unsaturated polymerizable group;

m is 1 to 6;

each X 1 is independently —O— or —NR 4 —, where R 4 is H or C 1 -C 4 alkyl; and

n is 0 or 1;

at least one monomer comprising at least two ethylenically unsaturated group; and

inorganic oxide filler.

2. The dental composition of claim 1 wherein the addition-fragmentation agent comprises at least two ethylenically unsaturated terminal groups.

3. The dental composition of claim 1 wherein the ethylenically unsaturated groups are (meth)acrylate groups.

4. The dental composition of claim 1 wherein Z comprises a vinyl, vinyloxy, (meth)acryloxy, (meth)acrylamido, styrenic and acetylenic functional groups.

5. The dental composition of claim 1 wherein Z is selected from:

wherein R 4 is H or C 1 -C 4 alkyl.

6. The dental composition of claim 1 wherein Q is selected from —O—, —S—, —NR 4 —, —SO 2 —, —PO 2 —, —CO—, —OCO—, —R 6 —, —NR 4 —CO—NR 4 —, NR 4 —CO—O—, NR 4 —CO—NR 4 —CO—O—R 6 —, —CO—NR 4 —R 6 —, —R 6 —CO—O—R 6 —, —O—R 6 —, —S—R 6 —, —NR 4 —R 6 —, —SO 2 —R 6 —, —PO 2 —R 6 —, —CO—R 6 —, —OCO—R 6 —, —NR 4 —CO—R 6 —, NR 4 —R 6 —CO—O—, and NR 4 —CO—NR 4 —,

wherein each R 4 is hydrogen, a C 1 to C 4 alkyl group, or aryl group, each R 6 is an alkylene group having 1 to 6 carbon atoms, a 5- or 6-membered cycloalkylene group having 5 to 10 carbon atoms, or a divalent arylene group having 6 to 16 carbon atoms, with the proviso that Q-Z does not contain peroxidic linkages.

7. The dental composition of claim 1 wherein Q is an alkylene or hydroxyl-substituted alkylene or aryloxy-substituted alkylene or alkoxy-substituted alkylene.

8. The dental composition of claim 1 wherein Q is an alkylene of the formula —C r H 2r —, where r is 1 to 10.

9. The dental composition of claim 1 wherein Q is a hydroxyl-substituted alkylene.

10. The dental composition of claim 1 wherein Q is —CH 2 —CH(OH)—CH 2 —.

11. The dental composition of claim 1 wherein Q is an aryloxy-substituted alkylene.

12. The dental composition of claim 1 wherein R 5 is an alkoxy-substituted alkylene.

13. The dental composition of claim 1 wherein R 1 —X 1 — groups (and optionally R 2 —X 2 — groups) is selected from H 2 C═C(CH 3 )C(O)—O—CH 2 —CH(OH)—CH 2 —O—, H 2 C═C(CH 3 )C(O)—O—CH 2 —CH(O—(O)C(CH 3 )═CH 2 )—CH 2 —O—, H 2 C═C(CH 3 )C(O)—O—CH(CH 2 OPh)—CH 2 —O—, H 2 C═C(CH 3 )C(O)—O—CH 2 CH 2 —N(H)—C(O)—O—CH(CH 2 OPh)—CH 2 —O—, H 2 C═C(CH 3 )C(O)—O—CH 2 —CH(O—(O)C—N(H)—CH 2 CH 2 —O—(O)C(CH 3 )C═CH 2 )—CH 2 —O—, H 2 C═C(H)C(O)—O—(CH 2 ) 4 —O—CH 2 —CH(OH)—CH 2 —O—, H 2 C═C(CH 3 )C(O)—O—CH 2 —CH(O—(O)C—N(H)—CH 2 CH 2 —O—(O)C(CH 3 )C═CH 2 )—CH 2 —O—, CH 3 —(CH 2 ) 7 —CH(O—(O)C—N(H)—CH 2 CH 2 —O—(O)C(CH 3 )C═CH 2 )—CH 2 —O—, H 2 C═C(H)C(O)—O—(CH 2 ) 4 —O—CH 2 —CH(—O—(O)C(H)═CH 2 )—CH 2 —O— and H 2 C═C(H)C(O)—O—CH 2 —CH(OH)—CH 2 —O—, H 2 C═C(H)C(O)—O—(CH 2 ) 4 —O—CH 2 —CH(—O—(O)C(H)═CH 2 )—CH 2 —O—, and CH 3 —(CH 2 ) 7 —CH(O—(O)C—N(H)—CH 2 CH 2 —O—(O)C(CH 3 )C═CH 2 )—CH 2 —O—.

14. The dental composition of claim 1 wherein the ethylenically unsaturated groups of the monomer are (meth)acrylate groups.

15. The dental composition of claim 1 wherein the monomer is an aromatic monomer having a refractive index of at least 1.50.

16. The dental composition of claim 1 wherein the monomer is a low volume shrinkage monomer.

17. The dental composition of claim 1 wherein the monomer is an isocyanurate monomer, a tricyclodecane monomer, or a mixture thereof.

18. The dental composition of claim 1 wherein the hardened dental composition exhibits a stress deflection no greater than 2.0.

19. The dental composition of claim 1 wherein the dental composition comprises at least one (meth)acrylate monomer selected from ethoxylated bisphenol A dimethacrylate (BisEMA6), 2-hydroxyethyl methacrylate (HEMA), bisphenol A diglycidyl dimethacrylate (bisGMA), urethane dimethacrylate (UDMA), triethlyene glycol dimethacrylate (TEGDMA), glycerol dimethacrylate (GDMA), ethylenegylcol dimethacrylate, neopentylglycol dimethacrylate (NPGDMA), polyethyleneglycol dimethacrylate (PEGDMMA), and mixtures thereof.

20. The dental composition of claim 1 wherein the filler inorganic oxide filler comprises nanoparticles.

21. The dental composition of claim 20 wherein the inorganic nanoparticles comprise silica, zirconia, or mixtures thereof.

22. The dental composition of claim 20 wherein the inorganic nanoparticles are in the form of nanoclusters.

23. A method of treating a tooth surface, the method comprising

providing a hardenable dental composition of claim 1 comprising an addition-fragmentation agent,

placing the dental composition on a tooth surface; and

hardening the hardenable dental composition.

24. The method of claim 23 wherein the dental composition further comprises at least one ethylenically unsaturated monomer with acid functionality.

25. A dental article comprising the hardenable dental composition of claim 22 at least partially hardened.

26. A method of treating a tooth surface, the method comprising providing an at least partially hardened dental article according to claim 25 , adhering the dental article on a tooth surface in the mouth of a subject.

27. The dental composition of claim 1 further comprising a redox hardening agent.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066430/0287 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2013
From: JOLY, GUY D.; KREPSKI, LARRY R.; GADDAM, BABU N.; ABUELYAMAN, AHMED S.; CRAIG, BRADLEY D.; DUNBAR, TIMOTHY D.; CAO, CHUNTAO; OXMAN, JOEL D.; FALSAFI, AFSHIN; MOSER, WILLIAM H.; BUI, HOA T.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 030748/0368 →